Article
In vivo impact of JAK3 A573V mutation revealed using zebrafish.
Cellular and molecular life sciences : CMLS - 27 May 2022
Basheer Faiza, Bulleeraz Vilasha, Ngo Viet Q T, Liongue Clifford, Ward Alister C
Abstract excerpt
BACKGROUND: Janus kinase 3 (JAK3) acts downstream of the interleukin-2 (IL-2) receptor family to play a pivotal role in the regulation of lymphoid cell development. Activating JAK3 mutations are associated with a number of lymphoid and other malignancies, with mutations within the regulatory pseudokinase domain common. METHODS: The pseudokinase domain mutations A572V and A573V were separately introduced into the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
